(Q54429405)

English

MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.

scientific article published on 5 May 2010

In more languages
default values for all languages
No label defined

No description defined

Statements

MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit